Back

Are there clinical implications of an antiphospholipid syndrome diagnosis in pulmonary embolism patients?

15 October 2016 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster Session 2 - DVT and pulmonary embolism Thrombosis / embolism ACVC Premium Access Acute Cardiovascular Care 2016

About the speaker

Photo
Doctor Daniel Alexandre Candeias Faria

University Hospital Center of Algarve, Faro (Portugal)

5 More presentations in this session

Presentation thumbnail
1 year prognosis in acute pulmonary embolism: validation of PESI and sPESI prognostic models.
Doctor J. Neiva (Viana do Castelo, PT)
Abstract
Presentation thumbnail
Eligibility criteria for non-vitamin K antagonist anticoagulants in patients with pulmonary embolism in a real world portuguese population
Doctor D. Candeias Faria (Faro, PT)
Abstract
Presentation thumbnail
Propensity score adjusted analysis of the association of thrombolytic therapy and 30-days outcome in patients with intermediate risk pulmonary embolism
Professor N. Radovanovic (Belgrade, RS)
Abstract
Presentation thumbnail
Reperfusion therapies for acute pulmonary embolism: the experience of a center
Doctor A. Barbosa (Santa Maria da Feira, PT)
Abstract
Presentation thumbnail
Thrombolytic therapy for pulmonary embolism in real clinical practice
Associate Professor I. Pochinka (Nizhny Novgorod, RU)
Abstract Slides

Access the full session

Session thumbnail
Poster Session 2 - DVT and pulmonary embolism

The Event

Event poster

Acute Cardiovascular Care 2016

15 October - 17 October 2016

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources